AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) said the FDA has granted marketing approval for Feraheme Injection for intravenous (IV) use as ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE